TY - JOUR
T1 - Nonpharmacological management of psychological distress in people with COPD
AU - Volpato, Eleonora
AU - Farver-Vestergaard, Ingeborg
AU - Brighton, Lisa Jane
AU - Peters, Jeannette
AU - Verkleij, Marieke
AU - Hutchinson, Ann
AU - Heijmans, Monique
AU - von Leupoldt, Andreas
N1 - Publisher Copyright:
Copyright ©The authors 2023.
Funding Information:
Support statement: A. von Leupoldt is supported by research grants from the Research Foundation – Flanders (FWO), Belgium (G0C1921N; GOA3718N), an infrastructure grant from the FWO and the Research Fund KU Leuven, Belgium (AKUL/19/06; I011320N), and by the ‘‘Asthenes’’ long-term structural funding Methusalem grant (METH/15/ 011) by the Flemish Government, Belgium. L.J. Brighton is supported by the National Institute for Health and Care Research (NIHR) Applied Research Collaboration South London (NIHR ARC South London) at King’s College Hospital NHS Foundation Trust, and an NIHR research partnership (NIHR 135171). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
Publisher Copyright:
© The authors 2023.
PY - 2023/3/31
Y1 - 2023/3/31
N2 - Psychological distress is prevalent in people with COPD and relates to a worse course of disease. It often remains unrecognised and untreated, intensifying the burden on patients, carers and healthcare systems. Nonpharmacological management strategies have been suggested as important elements to manage psychological distress in COPD. Therefore, this review presents instruments for detecting psychological distress in COPD and provides an overview of available nonpharmacological management strategies together with available scientific evidence for their presumed benefits in COPD. Several instruments are available for detecting psychological distress in COPD, including simple questions, questionnaires and clinical diagnostic interviews, but their implementation in clinical practice is limited and heterogeneous. Moreover, various nonpharmacological management options are available for COPD, ranging from specific cognitive behavioural therapy (CBT) to multi-component pulmonary rehabilitation (PR) programmes. These interventions vary substantially in their specific content, intensity and duration across studies. Similarly, available evidence regarding their efficacy varies significantly, with the strongest evidence currently for CBT or PR. Further randomised controlled trials are needed with larger, culturally diverse samples and long-term follow-ups. Moreover, effective nonpharmacological interventions should be implemented more in the clinical routine. Respective barriers for patients, caregivers, clinicians, healthcare systems and research need to be overcome.
AB - Psychological distress is prevalent in people with COPD and relates to a worse course of disease. It often remains unrecognised and untreated, intensifying the burden on patients, carers and healthcare systems. Nonpharmacological management strategies have been suggested as important elements to manage psychological distress in COPD. Therefore, this review presents instruments for detecting psychological distress in COPD and provides an overview of available nonpharmacological management strategies together with available scientific evidence for their presumed benefits in COPD. Several instruments are available for detecting psychological distress in COPD, including simple questions, questionnaires and clinical diagnostic interviews, but their implementation in clinical practice is limited and heterogeneous. Moreover, various nonpharmacological management options are available for COPD, ranging from specific cognitive behavioural therapy (CBT) to multi-component pulmonary rehabilitation (PR) programmes. These interventions vary substantially in their specific content, intensity and duration across studies. Similarly, available evidence regarding their efficacy varies significantly, with the strongest evidence currently for CBT or PR. Further randomised controlled trials are needed with larger, culturally diverse samples and long-term follow-ups. Moreover, effective nonpharmacological interventions should be implemented more in the clinical routine. Respective barriers for patients, caregivers, clinicians, healthcare systems and research need to be overcome.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150831271&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/36948501
UR - http://www.scopus.com/inward/record.url?scp=85150831271&partnerID=8YFLogxK
U2 - 10.1183/16000617.0170-2022
DO - 10.1183/16000617.0170-2022
M3 - Article
C2 - 36948501
SN - 0905-9180
VL - 32
JO - European Respiratory Review
JF - European Respiratory Review
IS - 167
M1 - 220170
ER -